Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancer
暂无分享,去创建一个
M. Zeegers | N. James | R. Bryan | F. V. van Schooten | D M Wallace | K. Cheng | F. V. van Osch | Sylvia H J Jochems | D. Wallace | R. Fayokun | C. G. Pauwels | Sylvia H. J. Jochems | C. Pauwels
[1] Jacques Ferlay,et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.
[2] M. Zeegers,et al. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. , 2016, International journal of epidemiology.
[3] M. Zeegers,et al. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses , 2016, European Journal of Epidemiology.
[4] G. Scherer,et al. Smoking behaviour and compensation: a review of the literature with meta-analysis. , 2014, Regulatory toxicology and pharmacology : RTP.
[5] B. Rubino,et al. Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients. , 2013, Urologic oncology.
[6] M. Zeegers,et al. The West Midlands Bladder Cancer Prognosis Programme: rationale and design , 2010, BJU international.
[7] S. Burchiel,et al. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. , 2010, IARC monographs on the evaluation of carcinogenic risks to humans.
[8] D. Silverman,et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. , 2009, Journal of the National Cancer Institute.
[9] D. Michaud,et al. Chronic inflammation and bladder cancer. , 2007, Urologic oncology.
[10] J. Manson,et al. Prospective Study of , 2007 .
[11] N. Malats,et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.
[12] M. Kogevinas,et al. NAT 2 slow acetylation , GSTM 1 null genotype , and risk of bladder cancer : results from the Spanish Bladder Cancer Study and meta-analyses , 2005 .
[13] R. Goldbohm,et al. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands) , 2004, Cancer Causes & Control.
[14] S R Tannenbaum,et al. Gender- and smoking-related bladder cancer risk. , 2001, Journal of the National Cancer Institute.
[15] G. Scherer. Smoking behaviour and compensation: a review of the literature , 1999, Psychopharmacology.
[16] L. V. van't Veer,et al. 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. , 1997, Mutation research.
[17] H. Tunstall-Pedoe,et al. Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts , 1995, BMJ.
[18] D. Hémon,et al. Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco , 1989, International journal of cancer.
[19] P. Vineis,et al. Bladder cancer and smoking in males: Types of cigarettes, age at start, effect of stopping and interaction with occupation , 1984, International journal of cancer.
[20] A. Miller,et al. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. , 1980, Journal of the National Cancer Institute.